NEW YORK (GenomeWeb) – Nanosphere announced today that it has completed a $10 million public offering.

The Northbrook, Illinois-based molecular diagnostics firm priced the offering at $.47 per share. Each share was coupled with a five-year warrant to purchase one share of common stock at an exercise price of $.70 per share.

The firm said in a statement that it plans to use the funds for working capital and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.